Jie Wu
10PUBLICATIONS
22CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (10)
Sort by Publication Date:
|Jun 11, 2025
Identification of alkynyl nicotinamide HSN748 as a RET solvent-front mutant inhibitor with intracranial efficacy.Ujjwol Khatri, Neetu Dayal, Kofi B Owusu
|Mar 04, 2024
Adaptive Darwinian off-target resistance mechanisms to selective RET inhibition in RET driven cancer.Vivek Subbiah, Mohamed A Gouda, J Bryan Iorgulescu
|Dec 01, 2023
Exceptional Responses to Selpercatinib in RET Fusion-Driven Metastatic Pancreatic Cancer.Deepak Bhamidipati, Sireesha Yedururi, Jason Huse
|Oct 02, 2023
RETooling the RET Inhibitor Pralsetinib for ESR1 Fusion-Positive Breast Cancer and Beyond.Jie Wu, Vivek Subbiah
|Apr 18, 2023
Targeting RET Solvent-Front Mutants with Alkynyl Nicotinamide-Based Inhibitors.Ujjwol Khatri, Neetu Dayal, Xueqing Hu
|Jun 08, 2021
The L730V/I RET roof mutations display different activities toward pralsetinib and selpercatinib.Tao Shen, Xueqing Hu, Xuan Liu
Pageof 2
Frequent Collaborators
3 joint publications
Blaine H M Mooers
3 joint publications
Vivek Subbiah
2 joint publications
Xueqing Hu
2 joint publications
Herman O Sintim
1 joint publications
P Teng
1 joint publications
John M Koomen
1 joint publications
Jane L Messina
1 joint publications
Jamie K Teer
1 joint publications
Funda Meric-Bernstam
1 joint publications
Neetu Dayal
